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Engineering, Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, PennsylvaniaABSTRACT Thrombin is released as a soluble enzyme from the surface of platelets and tissue-factor-bearing cells to trigger
ﬁbrin polymerization during thrombosis under ﬂow conditions. Although isotropic ﬁbrin polymerization under static conditions
involves protoﬁbril extension and lateral aggregation leading to a gel, factors regulating ﬁber growth are poorly quantiﬁed under
hemodynamic ﬂow due to the difﬁculty of setting thrombin ﬂuxes. A membrane microﬂuidic device allowed combined control of
both thrombin wall ﬂux (1013 to 1011 nmol/mm2 s) and the wall shear rate (10–100 s1) of a ﬂowing ﬁbrinogen solution. At
a thrombin ﬂux of 1012 nmol/mm2 s, both ﬁbrin deposition and ﬁber thickness decreased as the wall shear rate increased
from 10 to 100 s1. Direct measurement and transport-reaction simulations at 12 different thrombin ﬂux-wall shear rate conditions
demonstrated that two dimensionless numbers, the Peclet number (Pe) and the Damkohler number (Da), deﬁned a state diagram
to predict ﬁbrin morphology. For Da< 10, we only observed thin ﬁlms at all Pe. For 10< Da< 900, we observed either mat ﬁbers
or gels, depending on the Pe. For Da > 900 and Pe < 100, we observed three-dimensional gels. These results indicate that
increases in wall shear rate quench ﬁrst lateral aggregation and then protoﬁbril extension.INTRODUCTIONThe conversion of fibrinogen to fibrin by the enzyme
thrombin is a central event in the growth and stability of
a blood clot. Fibrinogen is a large (330-kDa) rodlike protein
found at high concentrations (9 mM) in plasma. Thrombin,
a serine protease formed on deposited platelets at the site
of a vascular injury, cleaves fibrinopeptides A and B from
the fibrinogen molecule to yield fibrin monomers. The
absence of fibrinopeptides leaves ‘‘holes’’ in which comple-
mentary ‘‘knobs’’ fit such that fibrin monomers assemble in
a half-staggered configuration to form protofibrils. Protofi-
brils aggregate laterally to form fibrin fibers, which then
aggregate and cross-link with each other to form a fibrin
gel. The kinetic competition between protofibril extension
and lateral aggregation can be regulated by salt and thrombin
levels, resulting in fine or coarse gels (1,2). These mecha-
nisms of fibrin gel formation are based on extensive studies
in purified protein systems under isotropic, no-flow condi-
tions (3–5). However, considerably less is known about
how these mechanisms are affected by the shear flows in
which blood clots must form in vivo.
Fibrin deposition decreases with increasing wall shear rate
over the range 50–2500 s1 in whole-blood perfusions over
rabbit subendothelium (6) and tissue-factor (TF)-rich extra-
cellular matrices (7). This inverse relationship between
wall shear rate and fibrin deposition is congruent with the
clinical observation that venous blood clots are fibrin-rich,
whereas arterial blood clots are platelet-rich. In addition to
shear rate, fibrin deposition depends on the rate of thrombinSubmitted September 7, 2009, and accepted for publication December 7,
2009.
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0006-3495/10/04/1344/9 $2.00generation. For instance, collagen-adherent platelets, in the
absence of wall-derived TF, can induce fibrin deposition at
venous shear stresses, but fibrin deposition is severely
depressed at arterial shear stresses (8). Immobilized TF, in
contrast, leads to thrombin generation sufficient to yield
fibrin even at arterial shear stresses (9). However, even on
immobilized TF, there is a shear-dependent effect on coagu-
lation due to the dilution of thrombin and fibrin monomers
by the flow field (10). The critical levels of TF needed to
trigger fibrin formation at venous and arterial levels have
been measured (11); however, a limitation of these flow
assays is that the amount of thrombin generated is unknown
and likely highly variable among individuals.
In lieu of experimental measurements of thrombin flux,
theoretical studies provide insight into the interplay between
flow, platelet function, and coagulation. Thrombin generation
under flow is predicted to be sensitive to shear rate (12,13). In
one model, thrombin flux increases almost linearly with
increasing wall shear rate based on an increase in the flux of
prothrombin to the prothrombinase complex at the site of an
injury (12). A second model predicts that thrombin flux
moderately decreases with increasing wall shear rate owing
to the role platelets play in blocking the TF/VIIa complex
(13). Neither of these models includes fibrin production.
Recently, a simplified model of coagulation in a shear flow
was used to predict the extent of fibrin gel formation as a func-
tion of wall shear rate (14). This model predicts that at venous
shear rates (<300 s1), thrombin concentration dictates gel
growth. However, at high shear rates, the model predicts
that gel growth is limited by the rate of removal of fibrin
monomers and oligomers by the flow field.
To date, there are no reports of fibrin deposition under
flow in a purified system at a defined thrombin wall flux.doi: 10.1016/j.bpj.2009.12.4275
Fibrin Deposition under Flow 1345The objective of this study is to determine under what condi-
tions fibrin can form under flow, and how those conditions
affect fibrin assembly and structure. We used a previously
developed membrane-based microfluidic technique (15) to
introduce thrombin at a defined flux into a flowing solution
of fibrinogen. These experiments provide a link between
blood flow assays and theoretical models of thrombin gener-
ation. Results demonstrate that fibrin deposition and
morphology in a shear flow are dictated by the interplay
between thrombin flux and wall shear rate. Scaling argu-
ments and computational models of the relevant conserva-
tion equations suggest that fibrin deposition can be
characterized by two dimensionless parameters, the Peclet
number (Pe) and the Damkohler number (Da). We propose
a state diagram for fibrin morphology based on these results
and discuss physiological relevance to bleeding and throm-
botic disorders.MATERIALS AND METHODS
Materials
Human fibrinogen (plasminogen, von Willebrand factor, and fibronectin-
depleted; Enzyme Research Laboratories, South Bend, IN) was received at
38 mM (12.62 mg/mL) in 20 mM sodium citrate-HCl and diluted to 9 mM
in Tris-buffered saline (TBS; 150 mM NaCl and 50 mM Tris-HCl, pH
7.4). Aliquots of 1 mL were stored at 80C, defrosted at 37C, and used
within 2 h. Approximately 1 mL of the stock fibrinogen (9 mM) was fluores-
cently labeled with an Alexa 647 fluorophore (A20173, Invitrogen, Carls-
bad, CA) using a protein labeling kit according to the manufacturer’s
instructions. Human a-thrombin was received at 3.44 mg/mL in 50 mM
sodium citrate/0.2 M NaCl/0.1% PEG-8000 at pH 6.5 (Enzyme Research
Laboratories) and was diluted to concentrations of 1000, 100 and 10 nM
in TBS that included 1 mg/mL bovine serum albumin to block thrombin
adsorption to tubing and polydimethylsiloxane (PDMS). Aliquots of
100 mL were stored at 80C, defrosted at 4C, and used within 2 h.
Alexa-488-labeled 1-mm-sulfate-modified polystyrene beads (F8852,
Invitrogen) were used for flow visualization. Fluorescein isothiocyanate
(FITC), inorganic salts, and gluteraldehyde were purchased from Sigma-
Aldrich (St. Louis, MO). Microfluidic channels were fabricated in PDMS
(Sylgard 184, Dow Corning, Midland, MI).Assembly and operation of membrane-
microﬂuidic device
The membrane-microfluidic device consists of a surface-modified polycar-
bonate membrane reversibly bonded between two PDMS channels oriented
perpendicular to each other (Fig. 1, and Fig. S1 in the Supporting Material).
The fabrication and assembly of the device was previously described (15)
and has been modified for this study. The geometry of the channel consisted
of two different cross-sectional areas; the middle fibrin deposition zone
(50 mm  250 mm) was bracketed on each side by a fluidic resistor
(15 mm  100 mm) (Fig. S1). To incorporate the membrane into the device
without leakage,we used a reversible bonding techniquewhere themembrane
was placed on a partially cured piece of PDMS (16). A detailed description of
the fabrication and assembly can be found in the Supporting Material.
Solutions of fibrinogen and thrombin in 1 mL syringes were connected to
the device with small-bore Tygon tubing (inner diameter 0.01 in, outer diam-
eter 0.03 in, Small Parts, Miramar, FL). Varying the height of these fibrin-
ogen and thrombin reservoirs controlled the wall shear rate and thrombin
flux through the membrane. The hydrostatic head of the fibrinogen reservoirdetermined the wall shear rate within the bottom channel. The difference in
hydrostatic head between the thrombin and fibrinogen reservoirs determined
the transmembrane pressure and, thus, the thrombin flux through the
membrane (Fig. 1). The thrombin reservoir was always positioned higher
than the fibrinogen reservoir so that the pressure gradient across the
membrane forced fluid from the upper channel (thrombin) into the lower
channel (fibrinogen). Wall shear rate was calculated by measuring the
velocity of tracer particles in the lower channel using a manual particle-
tracking macro (17) in ImageJ software (18). Thrombin flux was calculated
indirectly based on the flux of a FITC solution through the membrane for
a given operating condition. See the Supporting Material for a detailed
description of these measurements.
Before each fibrin deposition experiment, the lower channel was initially
filled with TBS and the upper channel with 100 mMFITC in TBS. The reser-
voir containing the FITC solution was oriented 0.5–1.5 in above the TBS
reservoir and adjusted appropriately to achieve a desired flux. After the
measurement of the FITC flux, a thrombin solution (10, 100, or 1000 nM)
was introduced into the upper channel to replace the FITC solution. After
flowing through a thrombin solution for 5 min, the fibrinogen solution
(9 mM) was introduced into the lower channel. The fibrinogen solution con-
tained a molar ratio of 100:1 fibrinogen/fibrinogen-AlexaFluor 647, 20 mM
CaCl2, and 1000-diluted polystyrene beads. The duration of the fibrin
deposition experiment was 5 min. Fibrin deposition was measured every
10 s by epifluorescence using a 20 objective in the area immediately down-
stream from where the two channels intersect.
Scanning electron microscopy of deposited ﬁbrin
Immediately after a flow experiment, the vacuumwas released, the top PDMS
piece was removed, and the membrane was peeled from the bottom piece of
PDMS.Themembranewas rinsed twice inTBS-BSAsolution for 5min, fixed
in 2.5% gluteraldehyde for 30 min, rinsed in TBS twice for 5 min, and then
rinsed in triplicate in sodium cacodylate buffer (0.2 M. pH 7.4) for 5 min.
Samples were then rinsed in graded ethanol solutions (50%, 70%, 80%,
90%, 100%, and 100%) for 5 min, and dehydrated once in 50% and twice
in 100% hexamethyldisilazane for 5 min each. A thin film (~10 nm) of gold
was sputtered on samples that were imaged by scanning electron microscopy
(SEM; JOEL 7000 field emission SEM, Hitachi, Tokyo, Japan). SEM images
were takenwith an accelerating voltage of 5 kV and a 6-mmworking distance.
The diameter of fibrin fibers was measured manually using ImageJ software
(18). In each image, 10–20 fibers were measured 10 times each. Fiber diam-
eters were reported as averages and standard deviations. Differences between
experimental conditions were determined by a Student t-test (p < 0.01).
Brightness and contrast were adjusted on SEM images to optimize viewing.
No other image manipulation was performed.THEORY
In the purified system used in this study, which contained
only fibrinogen and thrombin, the amount of fibrinogen con-
verted to fibrin monomers under flow was a function of the
thrombin flux and wall shear rate. The thrombin flux deter-
mined the concentration of thrombin in the boundary layer
and the wall shear rate determined the thickness of the
boundary layer. This problem is a version of the extended
Graetz problem with a Neumann boundary condition
(constant wall flux) in a finite region of a confined shear
flow. The nondimensionalized thrombin (ct), fibrinogen
(cf), and fibrin monomer (cm) conservation equations are
vct
vx
¼ 1
1 y2

1
Pe2
v2ct
vx2
þ v
2ct
vy2

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FIGURE 1 Membrane microfluidic
device, operation, and data analysis.
The device consists of two microfluidic
channels oriented perpendicular to each
other and separated by a polycarbonate
membrane. Fibrinogen is perfused
through the lower channel at a desired
wall shear rate. Thrombin is introduced
into the flowingfibrinogen at a controlled
flux. (A and B) The schematic depicts the
side and bottom views of the device. (C)
FITC is used as a tracer molecule to
measure flux through the membrane
before introduction of fibrinogen and
thrombin. (D–F) After the experiment,
deposited fibrin is fixed and imaged by
electron microscopy. The progression
of the polymerization is observed as
a function of distance from the channel
intersection. Scale bar, 1 mm.
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#TABLE 1 Experimental conditions and corresponding
simulation results of dimensionless parameters (Pe andDaf,max)
for the calculated boundary layer thickness andmeasured ﬁbrin
morphology
Wall shear
rate (s1)
Thrombin flux
(nmol/mm2 s) Pe Daf,max*
Boundary layer
thickness d (mm)
Measured
morphology
10 1013 19 12 >50 Film
10 1012 19 165 >50 Gel
10 1011 19 1647 >50 Gel
25 1013 47 7 31 Film
12f
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where Pe is the Peclet number and is defined as Pe ¼
vmaxH/Di (where Di is either the thrombin, fibrinogen, or
fibrin monomer diffusion coefficient in water, H is the
half-height of the channel), Daf and Dam are the fibrinogen
and monomer Damkohler numbers (defined as Daf ¼ ktH2/
Df and Dam ¼ kpcf,oH2/Dm). Da is a ratio of the reaction
rate to the diffusion rate. Pe represents the ratio of convective
transport to diffusive transport. Equations 1–3 are coupled
by the reaction rate, kt, since the Michaelis-Menten kinetics
is dependent on enzyme (thrombin) concentration. Details
of the scaling analysis and boundary conditions can be
found in the Supporting Material. Equations 1–3 were solved
simultaneously using commercial finite-element software
(COMSOL Multiphysics 3.4, COMSOL, Natick, MA) in
Poiseuille flow for the physical properties shown in Table
S1 and the geometry shown in Fig. S2. See the Supporting
Material for details of numerical method and comparison
to analytical solutions for ideal cases.
25 10 47 118 31 Mat
25 1011 47 1200 31 Gel
50 1013 94 5 23 Film
50 1012 94 85 23 Mat
50 1011 94 951 23 Gel
100 1013 190 4 18 Film
100 1012 190 54 18 Mat
100 1011 190 755 18 Mat
Fibrin morphology was measured by SEM.
*Daf,max was the maximum local fibrinogen Damkohler number from the
simulations and was located at y¼ 0 and x¼ 250 mm. Boundary layer thick-
ness was defined as the height at which thrombin concentration was 1% of
the wall concentration, at x ¼ 250 mm.RESULTS
We performed experimental and computational studies on
the role of wall shear rate and thrombin flux on fibrin depo-
sition and morphology. Table 1 summarizes the parameter
space we explored in these studies. Experimental studies
were conducted in a membrane microfluidic device (Fig. 1
and Fig. S1) that allowed independent manipulation of the
wall shear rate of a fibrinogen solution and the thrombin
flux into that solution. Fibrin deposition and morphologyBiophysical Journal 98(7) 1344–1352were measured by SEM and compared to simulations of
combined transport and reaction governing spatial dynamics
of fibrinogen, fibrin monomer, and thrombin.
Wall shear rate and ﬂux measurements
The imposed hydrostatic head was set to provide 1), convec-
tion-dominated transport through the membrane; and 2),
minimal perturbation of the flow field in the lower channel.
The first requirement had to be satisfied to ensure that there
was no diffusion of fibrinogen into the thrombin channel or
into the pores. If this requirement went unsatisfied, fibrin
would form in the pores and block the flow of thrombin
into the fibrinogen channel. The second requirement had to
be satisfied so that the flowing fibrinogen solution would
not be displaced by the thrombin solution in the lower
Fibrin Deposition under Flow 1347channel. We found that a difference hydrostatic head of
0.5–1.5 inches H20 (125–375 Pa) between the thrombin
reservoir and the fibrinogen reservoir satisfied these require-
ments. This results in a pore Peclet number range (Pepore ¼
vyrmembrane/Dt) of 3–9, indicating that within a pore, convec-
tive transport was the dominant transport mechanism. In
addition, when a dense suspension of beads was perfused
through the lower channel at wall shear rates of 10–100 s1,
these transmembrane pressures showed no evidence of per-
turbing the velocity profile.At higher transmembrane pressure
(>2 inH2O), the transmembrane flowdisplaced the oncoming
fibrinogen solution off the membrane by>10 mm. The linear
relationship between the wall shear rate (s1) in the lower
channel and the hydrostatic head (inches H2O) of the fibrin-
ogen reservoir was gw ¼ 2.79 DPFbg (R2 ¼ 0.98).
To estimate the flux of thrombin, we measured the flux of
a fluorescent tracer (FITC) from the thrombin (upper)
channel into the fibrinogen (lower) channel. During the
measurement, a 100-mM solution of FITC was perfused
through the thrombin channel and TBS was perfused through
the lower channel. The concentration of FITC (cFITC (mM))
in the lower channel immediately downstream (Fig. 1 C)
from the intersection of the two channels was calculated
from the fluorescence intensity (I) using a standard curve
(cFITC¼ 0.04 I 11, R2¼ 0.97). There was good agreement
between the theoretical (Eq. S32) and measured flux at wall
shear rates of 10, 25, 50, and 100 s1 (Fig. S3).
Real-time ﬁbrin deposition
Fibrin deposition during a flow experiment was measured by
epifluorescence microscopy in the region 250 mm down-
stream from the introduction of thrombin (Fig. 1 C). We
were able to qualitatively monitor in real time the growth
of larger fibers (>100 nm) and fiber aggregates. In most
experimental conditions, we observed a steady increase in
fluorescence intensity across the channel with time, but could
not resolve individual fibers. There was no decrease in flow
rate in the lower channel in these experiments, as determined
by the velocity of tracer beads. In these cases, SEM revealed
either a thin film of fibrin or a dense mat of small fibrin fibers.50
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FlowAt higher thrombin fluxes, there were observable fibers and
fiber aggregates in the channel (Fig. S1). These larger fibers
and fiber aggregates formed within the first minute of the
experiment and often grew at a rate that ultimately occluded
the channel before the end of the 5-min experiment.
A channel was considered occluded when polystyrene tracer
beads stopped flowing. However, if we stopped the experi-
ment after 1 min, we observed a gradient of fiber sizes as
a function of the downstream distance (Fig. 1, D–F). One
interpretation of this data is that the axial distance represents
the reaction coordinate of fibrin polymerization. At early
times (Fig. 1 D), monomers have only had time to form pro-
tofibrils. However, as we move further downstream, protofi-
brils have had time to laterally aggregate into fibers (Figs. 1,
E and F). Congruent with these observations, simulations
predict that fibrin monomer concentration was initially
high (~3 mM) and then decreased as they formed dimers
(Fig. S4). It is not clear whether fibers form in the bulk solu-
tion or grow on the surface, or both.
Effect of wall shear rate on mass transfer
and ﬁbrin morphology
Simulations of thrombin introduced at a defined wall flux
into a flowing fibrinogen solution identified reaction-limited
and mass-transfer-limited regimes over the wall shear rates
of 10 s1 to 100 s1 (Fig. 2). At the lowest wall shear rate
(10 s1), thrombin penetrated across the entire height of
the channel within the first 250 mm downstream from its
introduction into the flowing fibrinogen solution. No concen-
tration boundary layer formed at this moderate Peclet
number (Pe ¼ 19), giving rise to a reaction-limited regime
(Table 1). In the reaction-limited regime, and at a thrombin
flux of 1012 nmol/mm2 s, the simulation predicted that all
of the fibrinogen was converted into fibrin monomers within
500 mm downstream. In the experiment, at the same condi-
tions, we observed well-developed fibrin fibers (diameter
84 5 22 nm) on the surface of the membrane (Fig. 3 A).
In the reaction-limited regime at this thrombin flux, fibrin
monomers can form protofibrils and these protofibrils can
laterally aggregate into larger fibers.8 10
γ = 10 s-1
γ = 100 s-1
γ = 25 s-1
γ = 50 s-1
FIGURE 2 Thrombin and fibrinogen concentration
profiles from simulations at wall shear rates of 10, 25, 50,
and 100 s1 and a thrombin flux of 1012 nmol/mm2 s.
Thrombin is introduced at a constant flux from the top of
the channel from the origin (x ¼ 0 mm) to the dotted line
(x ¼ 250 mm). Direction of flow is from left to right.
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FIGURE 3 Fibrin morphology as a function of wall
shear rate. Electron micrographs of fibrin formed after
5 min at a thrombin flux of 1012 nmol/mm2 s and wall
shear rates of 10 s1 (A), 25 s1 (B), 50 s1 (C), and
100 s1 (D). Dark disklike objects in D are the membrane
pores. Scale bar, 1 mm.
1348 Neeves et al.As the wall shear rate increases, simulations predicted the
formation of a concentration boundary layer and the subse-
quent transition to a mass-transfer-limited regime for fibrin
formation (Fig. 2). At wall shear rates of >25 s1, the Peclet
number was large enough for convection to dominate diffu-
sive transport except within a thin concentration boundary
layer near the wall. The thickness of the concentration
boundary layer scaled as the Pe1/3 (Table 1), in agreement
with boundary layer theory (20). Based on the simulations,
we expected that as the boundary layer thickness decreased,
fibrin deposition would decrease, because less fibrinogen
would be converted into fibrin monomer (Fig. S4). Experi-
ments at these wall shear rates confirmed this expectation.
We observed a dramatic change in fibrin morphology
between wall shear rates of 10 s1 and 25 s1 (Fig. 3, A
and B). At 25 s1, the fibrin deposited on the membrane
took the form of a dense mat of thin fibers interconnected
by a thin film. These fibers were much smaller than the
mature fibers we observed at 10 s1 and were randomly
oriented on the surface. At 50 s1, a similar morphology
was observed, except that the fibers were sparser and tended
to align with the direction of flow.
At 100 s1, we observed no discernable fibers, only a thin
film of fibrin on the membrane surface (Fig. 3 D). A weblike
morphology over the 400-nm pores was consistently
observed downstream of thrombin introduction. There was
no evidence of these morphologies upstream of the
thrombin, suggesting that this morphology was a result of
fibrin monomer assembly and not just fibrinogen adsorption.
We were not able to resolve this webbing over the pores by
epifluorescence during the experiment. It is possible that
a contiguous film formed during the experiment and the
webbing is an artifact of the sample preparation for SEM.Biophysical Journal 98(7) 1344–1352However, similar fibrin thin film morphologies have been
observed in solution in static experiments between microfab-
ricated ridges spaced 25 mm apart (21).Fibrin deposition and morphology as a function
of thrombin ﬂux
Simulations predicted that the concentration of thrombin
within the concentration boundary layer was directly propor-
tional to the thrombin flux. However, the thickness and shape
of the concentration boundary layer were solely dependent
on wall shear rate. Results from simulations at thrombin
fluxes at 1013 and 1011 nmol/mm2 were identical except
for the magnitude of the thrombin concentration, as expected
by the linearity of Eq. 3. For example, at 1013 nmol/mm2 s,
the maximum thrombin concentration was 45 nM compared
to 450 nM for 1012 nmol/mm2 s.
At a constant wall shear rate of 25 s1, we observed
dramatic changes in fibrin deposition and morphology over
the thrombin flux range of 1013–1011 nmol/mm2
(Fig. 4). At the lowest thrombin flux (Fig. 4 A), we observed
a thin film morphology similar to that observed at 100 s1
and 1012 nmol/mm2 (Fig. 3 D). Increasing the thrombin
flux one order of magnitude yielded a few layers of fully
developed, cross-linked fibers (Fig. 4 B). At the highest
thrombin flux, we observed a dense fibrin gel that occluded
the channel within 2–3 min (Fig. 4 C).
At the lowest thrombin flux (1013 nmol/mm2 s), we did not
observe fiber formation at any of the wall shear rates, only
fibrin thin films. Simulations predict that the maximum
thrombin concentration at this flux was between 25 and
45 nM, depending on wall shear rate (Fig. 2). The maximum
fibrinogen Damkohler number at this flux ranges from 4 to 12
A10-13 nmol µm-2 s-1
B
10-12 nmol µm-2 s-1
C
10-11 nmol µm-2 s-1
FIGURE 4 Fibrin morphology as
a function of thrombin flux. Electron
micrographs of fibrin formed at a wall
shear rate of 50 s1 and thrombin flux
of 1013 (A), 1012 (B), and 1011 (C)
nmol/mm2 s. Dark disklike objects in A
are themembrane pores. Scale bar, 1mm.
Fibrin Deposition under Flow 1349(Table 1) over the wall shear rate range of 100 s1 to 10 s1,
indicating that fibrin monomer production was only moder-
ately faster than diffusion out of the boundary layer. Fibrin
monomer concentration was predicted to be relatively low
(<1 mM) at this thrombin flux compared to the other two
fluxes (Fig. S4). These simulation results suggest that either
protofibrils did not reach a minimum length (~10 monomers)
or lateral aggregation did not occur before protofibrils were
carried downstream at this low thrombin flux. To determine
whether the absence of fibers was due to incomplete conver-
sion of fibrinogen to monomer or not reaching a critical
concentration of protofibrils, we performed a set of experi-
ments at high thrombin flux (1011 nmol/mm2 s) and low
fibrinogen concentrations (300 nM). At this thrombin flux,
the thrombin concentration within the boundary layer was
as high as 4.5 mM according to simulation results, and all
fibrinogen was converted to fibrin monomer within the
boundary layer. Even at these high thrombin concentrations,
we observed no fibrin fibers under flow, only thin films.
Collectively, these experiments and simulations suggest that
below a threshold concentration of monomer, fiber growth
is not supported, and fibrin monomers and oligomers can
assemble into a thin film on a surface.
At the medium thrombin flux (1012 nmol/mm2 s), the
fibrin morphology was shear-rate-dependent, as described
in the previous section.
At the highest thrombin flux (1011 nmol/mm2 s), an
occlusive fibrin gel was observed at all wall shear rates
except 100 s1, where we observed only a dense mat of
surface fibers. There was not a statistically significant differ-
ence in fiber diameter (~755 25 nm) at wall shear rates of
10, 25, and 50 s1. Simulations at this high thrombin flux
predicted that almost all fibrinogen at the wall is converted
to fibrin monomer at 100 s1 and that all of that monomer
was converted to dimer within 250 mm downstream of
thrombin introduction. Since we observed surface fibers at
100 s1 fibers, albeit small ones compared to lower shear
rates, we conclude that the limitation to gel growth was trans-
port of reactants (monomers, oligomers, and protofibrils) out
of the boundary layer rather than the kinetics of fiber growth.
Fibrin morphology state diagram
Experimental results demonstrate that fibrin morphology is
a function of both thrombin flux and wall shear rate. Scaling
arguments of the thrombin, fibrinogen, and fibrin monomerconservation equations suggest that fibrin morphology is
a function of two dimensionless parameters; the Peclet (Pe)
and Damkohler (Da) numbers. The Peclet number describes
the ratio of convective to diffusive transport. At low Pe, prod-
ucts and reactants can diffuse across the height of the channel,
and fibrin polymerization is only limited by thrombin concen-
tration, and consequently reaction-limited. At high Pe, fibrin
polymerization is mass-transfer-limited due to transport of
reactants out of a thin concentration boundary layer near the
wall. For fibers to form, the rate of linear polymerization
and lateral aggregation must be faster than diffusion out of
the boundary layer. The Damkohler number describes the
ratio of these kinetic mechanisms to diffusion out of the
boundary layer. The Damkohler number for fibrinogen
(Daf) is coupled to the local thrombin concentration and
ranges over two orders of magnitude in experimental condi-
tions of the study (Table 1). The Damkohler number for fibrin
monomer (Dam) is 243, suggesting thatmonomers, if at a suffi-
ciently high concentration (>1mM),will react to form a dimer
before diffusing out of the boundary layer (Fig. S4). However,
protofibrils must reach some critical length (~10 monomers)
before they can laterally aggregrate. Consequently, the rate
of protofibril formation to diffusion may be closer to unity,
although a decrease in the diffusion coefficient would be
concomitant with each linear polymerization reaction.
Fig. 5 illustrates a state diagram for fibrin morphology
based on the scaling of the thrombin and fibrinogen conser-
vation equations and experimental observations. We have
divided the state diagram by the three qualitative morphol-
ogies we observed; thin films, two-dimensional fiber mats,
and three-dimensional gels. Under some experimental condi-
tions the morphology was clear, but in others there were
qualities of two morphologies (i.e., thin films and fibers).
Therefore, the boundaries between states are unlikely to be
sharp transitions. For Daf < 10, we only observed thin films
at all Pe. For 10 < Daf < 100, we observed either mats of
surface fibers or gels, depending on the Pe. For Daf > 900
and Pe < 100, we observed three-dimensional gels. As
Pe/0, we approach no-flow conditions (static gelation)
and would expect gels to exist at all Damkohler numbers.DISCUSSION
Fibrin provides a scaffold onto which blood clots grow and
stabilize. Although the kinetics of fibrin fiber and gelBiophysical Journal 98(7) 1344–1352
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FIGURE 5 Fibrin state diagram. Fibrin morphology can be described in
terms of the Peclet number and the Damkohler number as calculated from
simulations. Symbols represent observations from electron miscroscopy;
circles¼ three-dimensional gels, squares¼ two-dimensional mat, and trian-
gles ¼ thin films. Dashed lines represent the experimentally observed tran-
sitions between different morphologies.
1350 Neeves et al.assembly has been extensively studied in static systems,
there is less known about the role of hemodynamics in the
fibrin assembly process.
Although there are no direct measurements of the
thrombin flux from a clot formed in vivo, there are several
estimates based on the enzyme kinetics of the prothrombi-
nase complex and in vitro thrombin generation measure-
ments. Folie and McIntire performed simulations of platelet
agonist distribution from model thrombi in a shear flow (12).
In their study, thrombin flux was allowed to vary with wall
shear rate based on the conversion of prothrombin to
thrombin at the surface of thrombi according to the kinetics
of the prothrombinase complex. At 100 s1, they report
a thrombin flux of ~1011 nmol/mm2 s, which results in
a maximum thrombin concentration of ~1 mM. Since the pro-
thrombinase reaction is fast (kcat ¼ 30 s1), the rate of
thrombin production is only limited by the prothrombin
flux to the thrombi in their simulations (22). Therefore,
they report a roughly linear relationship between thrombin
flux and wall shear rate.
Kuharsky and Fogelson presented a more extensive model
of thrombin production under flow that includes the entire
extrinsic coagulation pathway and the role of platelet accu-
mulation in coagulation (13). In contrast to Folie and McIn-
tire, they predict a moderate decrease in thrombin flux with
increasing wall shear rate. For example, the steady-state
thrombin concentration within the concentration boundary
layer was reported as 70 nM at 100 s1 and 18 nM atBiophysical Journal 98(7) 1344–13521500 s1 for surface TF concentration >15 fmol/cm2. These
thrombin concentrations correspond to a thrombin flux
~1012 nmol/mm2 s. These contrasting results are likely
attributed to the fact that the Kuharsky model allows platelets
to inhibit the activity of surface-bound TF/VIIa. This
phenomenon of platelets inhibiting access to TF has since
been supported by experimental studies, albeit under static
conditions (23). The Kuharsky model also predicts that severe
hemophilia A and B (<1% normal factor levels) would result
in maximum thrombin concentrations of 1–10 nM, corre-
sponding to a thrombin flux of ~1013 nmol/mm2 s. Collec-
tively, these models suggest that the range of thrombin fluxes
(1013–1011 nmol/mm2 s) used in this study provided a good
estimate of what is physiologically feasible. These fluxes
correspond to thrombin concentrations that range from 10 to
1000 nM, which is also the typical range measured in
thrombin-generation assays (24).
Our results in a shear flow showed that formation of fibrin
fibers at moderate wall shear rates (100 s1) required a high
thrombin flux (~1011 nmol/mm2 s). This flux is close to the
maximum theoretical flux (1.4  1011 nmol/mm2 s) by the
prothrombinase complex based on 2700 binding sites per
thrombin-activated platelet and a rate of moles of thrombin
produced per mole of Xa of 30 s1 (25). Yet, even at arterial
shear rates there is evidence of fibrin formation in the pres-
ence of TF (9,11,26). One explanation that reconciles these
two observations is that fibrin polymerization is protected
from flow during thrombus growth in some areas. One
example is the recirculation flows that form downstream
from a stenosis. Studies in flow chambers demonstrate
enhanced platelet and fibrin accumulation in these areas
(27,28). A second example is the space between platelets
within a clot, which can be described as a Darcy-type flow
through a porous media. Intravital microscopy of clots
formed with the laser injury model show that fibrin accumu-
lation is enhanced near the vessel wall and within a growing
thrombus (29).
Experiments at low thrombin flux (1013 nmol/mm2 s) or
low fibrinogen concentration (300 nM) led to the formation
of fibrin thin films with no discernable fibers. It seems that at
low monomer concentrations, the assembly to thin films is
favored over fiber formation. One possible mechanism for
the assembly of fibrin thin films is the conversion of fibrin-
ogen to fibrin monomers by fibrin(ogen)-bound thrombin.
Riedel and colleagues provide evidence for this mechanism
of fibrin thin film growth on surfaces using different
thrombin inhibitors (30). In the presence of antithrombin
III and heparin, cleavage of fibrinopeptides by thrombin is
inhibited in solution. However, thrombin adsorbed to fibrin
(ogen) still has catalytic activity that is not blocked by anti-
thrombin III/heparin. O’Brien and colleagues propose
another mechanism in which fibrin thin films serve as
a precursor to fiber formation (21). In these experiments,
fibrin thin films self-assemble in gaps (25–40 mm) between
microfabricated features before condensing into fibrous
Fibrin Deposition under Flow 1351web. However, it is unknown whether these thin films can
form in vivo on a more complex surface like the subendothe-
lial matrix and in the presence of endogenous thrombin
inhibitors like thrombomodulin.
The mechanism of fibrin fiber assembly in static studies
suggests that gel morphology and fiber size are related to
the relative rates of protofibril extension and lateral aggrega-
tion (5,31). Under flow, these two mechanisms must also
compete with dilution of monomers and oligomers by the
velocity field. Our results suggest that for a given thrombin
flux, flow first quenches lateral aggregation and then protofi-
bril extension. This proposed mechanism is based on the
transitions we observed from a three-dimensional gel with
mature fibers to a two-dimensional dense mat of very thin
fibers, and finally to a thin film with no discernable fibers.
The quenching of lateral aggregation could be due to dimin-
ished interaction between adjacent aC domains on protofi-
brils, which has been shown to lead to thinner fibers in
certain dysfibrinogenemias (32).
It is important to recognize the differences between the
purified solutions used in this study and the more complex
composition of plasma when extrapolating results to physi-
ology and pathology in the body. Thrombin inhibitors like
antithrombin III in the plasma and thrombomodulin on the
surface of endothelial cells are known to limit the growth
of a fibrin clot. In addition, calcium concentration is known
to influence lateral aggregation. In this study, we used
a higher concentration of calcium (20 mM) than found in
the plasma (2 mM), which may have favored more lateral
aggregation. Other molecules that have been shown to affect
fibrin assembly include thrombospondin, platelet factor 4,
and polyphosphate (33–35). Future studies are needed to
determine the role of other plasma proteins, especially
thrombin inhibitors, and platelets in fibrin formation under
flow. Furthermore, the rheology of a whole blood will likely
influence the assembly and deposition of fibrin. Anand and
colleagues developed a model of clot formation that includes
the non-Newtonian constitutive relationships of whole blood
and the fibrin clot (36). Although that model is much more
complex than the simple two-component model of this study,
similar trends are observed in terms of a threshold concentra-
tion of fibrin monomer needed for fibrin gel formation.
The proposed fibrin state flow diagram has physiological
relevance to bleeding and thrombotic disorders. Individuals
with hemophilia have an impaired ability to generate
thrombin due to deficiencies in coagulation factors. Conse-
quently, they form smaller, less stable clots that lead to pro-
longed bleeding. Clinically, hemophilia often presents itself
in joint and intramuscular bleeds, which are low-shear-stress
environments similar to those investigated in this study. We
did not observe fibrin fibers at the thrombin fluxes we might
expect in hemophilia blood. For some thrombotic disorders,
such as deep-vein thrombosis, one of the primary risk factors
is decreased blood flow caused by compression of veins or
trauma. This decrease in blood flow could cause a transitionfrom a mass-transfer-limited to a reaction-limited regime,
resulting in an occlusive fibrin clot.SUPPORTING MATERIAL
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